Infosys: Quotes, News

BSE 1300.4524.2 (-1.86%)

NSE 1300.8025.1 (-1.93%)

Shree Cements: Quotes, News

BSE 23135.00133.85 (-0.58%)

NSE 23125.00140 (-0.61%)

Infosys Technologies

Angel Broking has a buy on the Infosys stock with a price target of Rs 3730. "We value the stock at 17.5x FY2015E EPS of Rs 213.3, which gives us a target price of Rs 3,730. We recommend an accumulate rating on the stock," the firm has stated in its research report.

Shree Cements

Firstcall Research has a buy call on Shree Cements with a target price of Rs 4840. "India's potential in infrastructure is vast. It has the capacity to become the world's third largest construction market by 2025, adding 11.5 million homes a year to become a US$ 1 trillion a year market, according to a study by Global Construction Perspectives and Oxford Economics. This opens up a tremendous window of opportunity for the country's cement industry," the firm has stated in its research report.

Sun Pharma

Systemix has recommended buying shares of Sun Pharma.

"Sun Pharma is currently trading above important support level of Rs 585. It also managed to close above upper Bollinger band. The volumes are higher since last 5 days indicating good accumulation after break‐out .RSI above 60 level indicate rising momentum in the counter. Traders can buy at or above Rs 600 for a target of Rs 619 with a stop loss of Rs 589," Systemix has said in a report.

City Union Bank

Firstcall has a buy on City Union Bank with a target of Rs 58.

"We expect that the company will keep its growth story in the coming quarters also. We recommend ‘BUY' in this particular scrip with a target price of Rs. 58.00 for Medium to Long term investment," the firm has said.

GoodReturns.in